Novartis AG (TSX:NVS)

Novartis AG Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	384,478	281,574	273,591	263,170	249,311	274,012
Market Cap Growth	37.01%	2.92%	3.96%	5.56%	-9.01%	-1.69%
Enterprise Value	415,958	306,296	291,453	276,969	283,488	310,411
PE Ratio	19.18	16.39	13.95	27.96	8.20	26.64
PS Ratio	4.90	3.78	4.44	4.47	4.48	4.31
PB Ratio	6.17	4.43	4.43	3.27	2.91	3.80
P/TBV Ratio	-	-	-	69.00	21.01	-
P/FCF Ratio	14.10	12.04	15.46	14.60	14.07	17.38
P/OCF Ratio	13.10	11.11	14.33	13.66	13.07	15.75
EV/Sales Ratio	5.34	4.12	4.73	4.71	5.09	4.88
EV/EBITDA Ratio	11.95	10.30	12.60	14.68	14.33	16.32
EV/EBIT Ratio	14.72	13.04	17.46	22.21	20.43	24.00
EV/FCF Ratio	15.25	13.10	16.47	15.36	16.00	19.69
Debt / Equity Ratio	0.72	0.71	0.57	0.47	0.46	0.67
Debt / EBITDA Ratio	1.27	1.50	1.49	1.97	1.95	2.49
Debt / FCF Ratio	1.64	1.93	1.97	2.10	2.22	3.08
Asset Turnover	0.54	0.51	0.43	0.35	0.34	0.41
Inventory Turnover	2.17	2.20	1.84	1.67	1.65	2.31
Quick Ratio	0.58	0.79	0.88	1.00	1.25	0.65
Current Ratio	0.88	1.03	1.16	1.29	1.51	0.90
Return on Equity (ROE)	32.62%	26.27%	16.15%	9.51%	36.80%	14.38%
Return on Assets (ROA)	12.13%	10.09%	7.27%	4.62%	5.28%	5.16%
Return on Capital (ROIC)	16.78%	13.72%	9.84%	6.18%	7.08%	7.07%
Return on Capital Employed (ROCE)	27.20%	22.20%	17.20%	10.40%	10.80%	10.70%
Earnings Yield	5.21%	6.10%	7.17%	3.58%	12.19%	3.75%
FCF Yield	7.09%	8.30%	6.47%	6.85%	7.11%	5.75%
Payout Ratio	54.32%	63.85%	48.85%	107.92%	30.67%	86.56%
Buyback Yield / Dilution	3.84%	2.73%	4.78%	2.79%	1.57%	0.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.